In the Know

Congress Sits on Proposed New Rules for FDA-Regulated Industries Pending Election Outcomes
March 14, 2012
Alerts
Arnall Golden Gregory LLP

More than 70 bills to amend the way that foods, drugs, cosmetics and medical devices are governed in the U.S. have been introduced in the past year. While most of these proposals may never come to a vote, the topics are an interesting reflection of public and private safety and economic concerns—and if some proposals would seem to be dead at present, a change in the Congressional majorities could mean a revival and rescue from the House and Senate Subcommittees where they currently languish.

Click the link below to read the full alert.

Downloads: